Intra-articular Bevacizumab for Recurrent Hemarthroses at Target Joints With Chronic Hemophilic Synovitis
NCT02060305
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
5
Enrollment
OTHER
Sponsor class
Stopped
Very slow enrollment
Conditions
Hemophilia
Synovitis
Interventions
DRUG:
Bevacizumab intra-articular injection
Sponsor
National Taiwan University Hospital